Skip to Content

Rule

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning 2-Guanidinylimidazolinedione Compounds and Methods of Making and Using Thereof

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Department of the Army, DoD.

ACTION:

Notice.

SUMMARY:

In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Provisional Patent Application No. 60/523,670 entitled “2-Guanidinylimidazolinedione Compounds and Methods of Making and Using Thereof,” filed November 21, 2003. The United States Government, as represented by the Secretary of the Army, has rights in this invention.

ADDRESSES:

Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The present invention relates to 2-guanidinylimidazolinedione Start Printed Page 9304compounds, methods of making and purifying 2-guanidinylimidazolinedione compounds, and methods of using the 2-guanidinylimidazolinedione compounds to prevent, treat, or inhibit malaria in a subject.

Start Signature

Luz D. Ortiz,

Army Federal Register Liaison Officer.

End Signature End Supplemental Information

[FR Doc. 04-4380 Filed 2-26-04; 8:45 am]

BILLING CODE 3710-08-M